Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States

(See the editorial commentary by Jain et al, on pages 707–709.) Background. Peramivir, an investigational intravenous neuraminidase inhibitor in Phase 3 trials for hospitalized patients, was made available during the 2009 H1N1 influenza pandemic under the Emergency Investigational New Drug (eIND) re...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Jaime E., Adiga, Raghavendra, Armstrong, Robert, Bazan, Jose, Bonilla, Hector, Bradley, John, Dretler, Robin, Ison, Michael G., Mangino, Julie E., Maroushek, Stacene, Shetty, Avinash K., Wald, Anna, Ziebold, Christine, Elder, Jenna, Hollister, Alan S., Sheridan, William
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049340/
https://www.ncbi.nlm.nih.gov/pubmed/21367722
http://dx.doi.org/10.1093/cid/cir001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049340/
https://www.ncbi.nlm.nih.gov/pubmed/21367722
http://dx.doi.org/10.1093/cid/cir001

Ejemplares similares